Daratumumab-induced in vivo immune modulation in relapsed and/refractory multiple myeloma patients treated with daratumumab-len-dex
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
and/refractory multiple myeloma patients,multiple myeloma,vivo immune modulation,daratumumab-induced,daratumumab-len-dex
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要